Publications by authors named "James H Ho"

Introduction: There have been concerns about prosthesis failure and the potential for systemic toxicity due to release of cobalt and chromium from metal-on-metal hip joint prostheses (MoM-HP). There is conflicting evidence on whether there is a correlation between higher cobalt and chromium concentrations and systemic toxicity.

Methods: We undertook a retrospective review of consecutive patients with MoM-HP referred for outpatient review in toxicology clinics in London, UK, and in the USA recorded in the Toxicology Investigators Consortium (ToxIC) Registry from June 2011 to June 2015.

View Article and Find Full Text PDF

Context: Synthetic cannabinoid receptor agonists are the largest group of new psychoactive substances reported in the last decade; in this study we investigated how commonly these drugs are found in patients presenting to the Emergency Department with acute recreational drug toxicity.

Methods: We conducted an observational cohort study enrolling consecutive adult patients presenting to an Emergency Department (ED) in London (UK) January-July 2015 (6 months) with acute recreational drug toxicity. Residual serum obtained from a serum sample taken as part of routine clinical care was analyzed using high-resolution accurate mass-spectrometry with liquid-chromatography (HRAM-LCMSMS).

View Article and Find Full Text PDF
Article Synopsis
  • Synthetic Cannabinoid Receptor Agonists (SCRAs) are a rapidly evolving group of new psychoactive substances that pose challenges in predicting their harms in pre-clinical studies.
  • A case involving a 19-year-old female revealed serious health effects, including seizures and hallucinations, after she consumed "cannabis tea" and LSD, which contained confirmed SCRAs (5FAKB-48 and 5F-PB-22).
  • This case underscores the complexities in understanding SCRAs' toxicity, especially in patients with existing mental health conditions treated with medications like fluoxetine and citalopram.
View Article and Find Full Text PDF

Purpose: Ethylphenidate is a novel psychoactive substance that is an analogue of methylphenidate. This paper describes its availability, patterns of use, and acute effects.

Methods: Searches of the scientific and grey literature (publicly accessible Internet resources) were undertaken, using the keywords "Ethylphenidate", "Ethyl phenidate", "Ethyl phenyl(piperidin-2-yl)acetate", and "Nopaine", to identify information on the prevalence and patterns of use, desired effects, and toxicity of ethylphenidate.

View Article and Find Full Text PDF